Clinical Outcomes with Direct Oral Anticoagulants Compared to Low Molecular Weight Heparins in the Treatment of Cancer-Associated Venous Thromboembolism

被引：0
|
作者：
Park, Deborah Y. [1 ]
Poudel, Shyam K. [2 ]
Jia, Xuefei [3 ]
Wilks, Mailey Lynn [2 ]
Pinkava, Vicki [2 ]
O'Brien, Meghan [2 ]
Tripp, Barbara [2 ]
Song, Jung-Min [2 ]
McCrae, Keith R. [2 ]
Angelini, Dana E. [2 ]
Khorana, Alok A. [2 ]
机构：
[1] Cleveland Clin, Lerner Coll Med, Cleveland Hts, OH USA
[2] Cleveland Clin Fdn, Dept Hematol & Med Oncol, Taussig Canc Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA
[3] Cleveland Clin, Quantitat Hlth Sci, Cleveland, OH 44106 USA
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-111897
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1237
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Cost-effectiveness of direct oral anticoagulants for cancer-associated venous thromboembolism
    King, J.
    Bhat, S.
    Heath, L. J.
    Derington, C. G.
    Yu, Z.
    Clark, N. P.
    Witt, D. M.
    Reynolds, K.
    Lang, D. T.
    Xu, S.
    Bellows, B. K.
    EUROPEAN HEART JOURNAL, 2019, 40 : 3140 - 3140
  • [32] Assessment of venous thromboembolism treatment in patients with cancer on low molecular weight heparin, warfarin, and the direct oral anticoagulants
    Uppuluri, Ellen M.
    Burke, Kelly R.
    Haaf, Christina Mactal
    Shapiro, Nancy L.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019, 25 (02) : 261 - 268
  • [33] Cost-effectiveness of apixaban versus other direct oral anticoagulants and low-molecular-weight-heparins for cancer associated venous thromboembolism in Spain.
    Munoz Martin, Andres J.
    Diaz, Enrique Gallardo
    Crespo, Carlos
    Domenech, Roma Masana
    Soto, Javier
    Arumi, Daniel
    Fernandez, Susana
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [34] Role of direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism: guidance from the SSC of the ISTH
    Khorana, A. A.
    Noble, S.
    Lee, A. Y. Y.
    Soff, G.
    Meyer, G.
    O'Connell, C.
    Carrier, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2018, 16 (09) : 1891 - 1894
  • [35] Safety and Efficacy of Direct Oral Anticoagulants vs Low Molecular Weight Heparin for Treatment of Venous Thromboembolism in Patients With Cancer
    Singh, Sahib
    Tantry, Udaya
    Bliden, Kevin
    Gurbel, Paul
    CIRCULATION, 2023, 148
  • [36] Clinical Outcomes of Cancer-Associated Venous Thromboembolism in Patients with Gastrointestinal or Genitourinary Cancers Treated with Direct Oral Anticoagulant Vs. Low Molecular Weight Heparin
    Upadhyaya, Kristi
    Chen, Xiaoying
    Khorana, Alok A.
    Angelini, Dana Elizabeth
    BLOOD, 2024, 144 : 5086 - 5087
  • [37] Comparative Efficacy of Oral Apixaban and Subcutaneous Low Molecular Weight Heparins in the Treatment of Cancer-Associated Thromboembolism: A Meta-Analysis
    Baloch, Maryam F.
    Adepoju, Adedimeji, V
    Falki, Vaibhavkumar
    Hajjaj, Mohsin
    Habet, Tatiana
    Habet, Karina
    Mahrosh, Amtul
    Kundu, Sumana
    Kataria, Janvi
    Mathew, Midhun
    Saka, Tugba
    Al-Tawil, Mohammed
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (08)
  • [38] Low-molecular-weight heparins in the treatment of venous thromboembolism
    Koopman, MMW
    Büller, HR
    ANNALS OF INTERNAL MEDICINE, 1998, 128 (12) : 1037 - 1039
  • [39] Comparison of Rivaroxaban and Low Molecular Weight Heparin in the Treatment of Cancer-Associated Venous Thromboembolism
    Coleman, Craig, I
    Caroti, Kimberly Snow
    Abdelgawwad, Khaled
    Psaroudakis, George
    Rivera, Marcela
    Brobert, Gunnar
    Cohen, Alexander T.
    Khorana, Alok A.
    Becattini, Cecilia
    Lee, Agnes Y.
    Ekbom, Anders
    Carrier, Marc
    BLOOD, 2022, 140 : 11368 - 11369
  • [40] Low molecular weight heparins: the optimal treatment for venous thromboembolism
    Daskalopoulos, ME
    Daskalopoulou, SS
    Liapis, CD
    CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (07) : 1001 - 1005
12345